Is This Beaten-Up Cannabis Stock Like Buying Aurora Cannabis (TSX:ACB) in 2016?

Zenabis Global (TSXV:ZENA) is not a name that is usually on most marijuana investors’ radars. Then again, in this post-legalization environment, it’s easy to see how a company like Zenabis, which has yet to complete its initial cultivation ramp up, can be overlooked in lieu of a name like Aurora Cannabis, which is selling products and battling for market share.…

Read More

Why We Aren’t Seeing Many Big Cannabis Deals With Other Industries

Cannabis is still very polarizing for consumers and investors. While it presents a great opportunity, with it being a brand-new industry to get involved in, it also presents a risk, particularly for established companies. Branding is important, and if a company gets it wrong, it could risk alienating its existing consumers, which would be bad news for its stock. Warren…

Read More

BioLumic, Ltd. Raises $6.7 million in Series A Led by Finistere Ventures, Canopy Rivers, Inc. (TSXV: RIV) (OTC Pink: CNOPF) Invests $1.5 Million

BioLumic, Ltd. is a New Zealand-based agriculture technology company that has developed a sustainable ultraviolet (UV) crop yield enhancement system. The technology is designed to improve yield and consistency, while reducing and even eliminating extra chemicals. This makes BioLumic’s technology, clean, environmentally-friendly and GM-free. The “technology activates natural mechanisms in seeds and seedlings that increase plant growth, vigor, and natural…

Read More

At What Price Does Canopy Growth (TSX:WEED) Become a Good Investment?

Now that marijuana stocks have somewhat stabilized, it’s time for investors to take a good look at where they should put their next dollars. Of the top tier marijuana stocks out there, it’s pretty much impossible to argue that Canopy Growth Corp.  (TSX:WEED)(NYSE:CGC) isn’t number one. But that doesn’t necessarily mean you should buy it at any moment. This industry is…

Read More

Why Health Canada’s Recent Announcement Could Be Bad News for Canopy Growth (TSX:WEED)

We could be seeing a lot more competition in the cannabis industry very soon. Health Canada recently announced that it would be making it easier for companies to obtain cannabis licenses. Previously, applicants didn’t have to have their sites ready to go before submitting their applications, which has created a lot of back-and-forth that wasn’t necessary that the government felt…

Read More

3 Reasons Aurora Cannabis (TSX:ACB) Q3 Results Weren’t All That Impressive

Aurora Cannabis Inc  (TSX:ACB)(NYSE:ACB) hit $65 million in net revenue in its most recent quarter. It was quadruple the $16 million in sales that the company did a year ago, but that doesn’t tell the whole story. Here are my three takeaways from the company’s Q3 results. Sales were up, but still not where they were supposed to be Investors…

Read More

Alternate Health Corp. (OTCQB: AHGIF) (CSE: AHG) Rallies 21% After Announcing Strategic Shift In CBD Positioning

Alternate Health Corp. (OTCQB: AHGIF) (CSE: AHG) operates in the CBD industry, which includes extraction, product development, distribution, research, and more. The company’s subsidiary, Blaine Labs, is a cGMP medical product manufacturing and distribution business, “with over 50 product SKUs available from major retailers including Walmart, Amazon, CBS, and Walgreens,” according to the company. The U.S.-listed shares of the CBD…

Read More

Investor Alert: Canopy Growth (TSX:WEED) Falls 15% in the Last Month and Aurora Cannabis (TSX:ACB) Reports a Disappointing Quarter

The S&P/TSX Composite Index is 2.5% below its highs at the time of writing today, as the broad market selloff continues. With this, we are seeing increasingly nervous investors that are becoming more aware of the risks out there and less willing to overlook them. As far as risk goes, the cannabis industry is certainly fraught with it, if only…

Read More

5 Takeaways From CannTrust Holdings’s (TSX:TRST) Redeeming Q1 Earnings

Canadian marijuana producer CannTrust Holdings (TSX:TRST)(NYSE:CTST) stock rallied as high as 11% during morning trade on Tuesday, as the market reacted to the company’s latest quarterly earnings installment. Investors had some justifiable reasons to celebrate the company’s redeeming set of financials after a poor show in a previous quarter. I’ll discuss some notable takeaways from the quarterly installment. A strong…

Read More